ScholarIQanswers from OpenAlex

Understanding drivers of vaccine hesitancy among pregnant women in Nigeria: A longitudinal study

PaperCitations, authors & open-access status

Understanding drivers of vaccine hesitancy among pregnant women in Nigeria: A longitudinal study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Understanding drivers of vaccine hesitancy among pregnant women in Nigeria: A longitudinal study have?

ScholarIQcitation count

Understanding drivers of vaccine hesitancy among pregnant women in Nigeria: A longitudinal study has 39 citations in the OpenAlex counts ScholarIQ stores.

When was Understanding drivers of vaccine hesitancy among pregnant women in Nigeria: A longitudinal study published?

ScholarIQyear

Understanding drivers of vaccine hesitancy among pregnant women in Nigeria: A longitudinal study has 2022 year in the ScholarIQ index.

What is the open-access status of Understanding drivers of vaccine hesitancy among pregnant women in Nigeria: A longitudinal study?

ScholarIQoa status

Understanding drivers of vaccine hesitancy among pregnant women in Nigeria: A longitudinal study has gold oa status in the ScholarIQ index.

What is the DOI of Understanding drivers of vaccine hesitancy among pregnant women in Nigeria: A longitudinal study?

ScholarIQdoi

The DOI for Understanding drivers of vaccine hesitancy among pregnant women in Nigeria: A longitudinal study is on the source record.

What is the PMID of Understanding drivers of vaccine hesitancy among pregnant women in Nigeria: A longitudinal study?

ScholarIQpmid

The PMID for Understanding drivers of vaccine hesitancy among pregnant women in Nigeria: A longitudinal study is on the source record.

What is the OpenAlex record for Understanding drivers of vaccine hesitancy among pregnant women in Nigeria: A longitudinal study?

ScholarIQopenalex

The OpenAlex for Understanding drivers of vaccine hesitancy among pregnant women in Nigeria: A longitudinal study is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial